COMP <GO>
ORCL vs AVGO // EV/EBITDA & P/E VALUATION
Oracle Corporation (NYSE) VS. Broadcom Inc. (NASDAQ) • 15-METRIC TALLY: ORCL 4
— AVGO 10
▲ EV/EBITDA & P/E VALUATION LEADER: ORCL
LAST: $130.67 (-6.37%) • MKT CAP: $405.97B
valuation
17.9x
LAST: $326.08 (-5.48%) • MKT CAP: $1.55T
valuation
34.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORCL VS. AVGO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ORCL | AVGO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 68.77% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.39% | 24.73% | -13.34 | AVGO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.9x | 34.1x | -16.20 | ORCL | /valuation <GO> |
| Free Cash Flow Yield | -7.07% | 2.55% | -9.62 | AVGO | /fcf-yield <GO> |
| Operating Margin | 32.12% | 48.05% | -15.93 | AVGO | /operating-margins <GO> |
| Net Profit Margin | 26.36% | 42.94% | -16.58 | AVGO | /net-margins <GO> |
| Revenue Growth (YoY) | 21.62% | 48.69% | -27.07 | AVGO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.53% | 0.80% | +0.73 | ORCL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.54 | 12.08 | -10.54 | AVGO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | AVGO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 11.57% | 8.98% | +2.59 | AVGO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.6 | 40.8 | +4.86 | ORCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.37 | 1.82 | -0.45 | AVGO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.5x | 19.0x | -2.47 | ORCL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $405.97B | $1.55T | -$1.14T | AVGO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ORCL REV | AVGO REV | ORCL GROSS % | AVGO GROSS % | ORCL FCF | AVGO FCF |
|---|---|---|---|---|---|---|
| FY 2026 | $67.36B | — | — | — | -$23.69B | — |
| FY 2025 | $57.40B | $63.89B | — | 67.8% | -$394.0M | $26.91B |
| FY 2024 | $52.96B | $51.57B | — | 63.0% | $11.81B | $19.41B |
| FY 2023 | $49.95B | $35.82B | — | 68.9% | $8.47B | $17.63B |
| FY 2022 | $42.44B | $33.20B | — | 66.5% | $5.03B | $16.31B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORCL // BETA 1.37
AVGO // BETA 1.82